InvestorsHub Logo
Followers 467
Posts 26912
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 117

Wednesday, 05/29/2013 9:38:46 AM

Wednesday, May 29, 2013 9:38:46 AM

Post# of 170
6:45AM Sucampo Pharma achieves orphan designation for unoprostone isopropyl for treatment of retinitis pigmentosa by European Medicines Agency (SCMP) 8.64 : Co announced that it has received orphan drug designation in the European Union for unoprostone isopropyl for the treatment of retinitis pigmentosa (RP). There are no drugs or therapeutic procedures currently approved for the treatment of RP today.